【摘 要】
：
Background Hepatocellular carcinoma (HCC) is a common malignancy worldwide with high morbidity and mortality.The prognosis for HCC is very poor, mainly because early diagnosis is often not feasible.Gu
【机 构】
：
Key Laboratory of Combined Multi-organ Transplantation, Ministry of Public Health;Department of Hepa
【出 处】
：
2015浙江省肿瘤外科学术年会暨首届钱江国际肿瘤外科高峰论坛
论文部分内容阅读
Background Hepatocellular carcinoma (HCC) is a common malignancy worldwide with high morbidity and mortality.The prognosis for HCC is very poor, mainly because early diagnosis is often not feasible.Gut microbiota is closely associated with HCC progression by microbiota-liver axis.Here we first identify gut microbial characteristics in clinical HCC by amplifying 16S ribosomal RNA of fecal microbiota in 105 early HCC patients and 131 healthy counterparts.
其他文献
达芬奇系统用于腹腔镜下左半结肠癌手术及肝脏转移瘤切除术治疗同时性结直肠癌伴肝转移在技术上是安全可行的，且相对于传统的分期手术或同期大切口、多切口手术具有明显的优势，达芬奇机器人腹腔镜较单纯腹腔镜具有学习时间短，图像三维立体感强以及在狭小空间灵巧度高等优势，符合现代外科微创、精准的发展趋势，为部分高度选择的同时性结直肠癌肝转移患者的治疗提供了较好的选择方案，可以减少手术次数，便于辅助化疗的管理及可能
目的：探讨血清微小RNA--222-3p (miR-222-3p)在甲状腺乳头状癌(PTC)中的表达及其临床意义.方法：提取121例甲状腺乳头状癌及甲状腺良性疾病患者血清中的总RNA,采用qRT-PCR方法检测miR-222-3p的表达情况,分析其与PTC临床病理特征的关系,并探讨其对PTC的临床诊断价值.结果：血清miR-222-3p在PTC患者中的中位表达水平显著高于甲状腺良性疾病组(2.21
目的：探讨SUMO4基因在甲状腺乳头状癌(papillary thyroid carcinoma,PTC)中的表达及其意义.方法：采用实时荧光定量PCR、Western blot及免疫组化方法检测甲状腺乳头状癌及正常甲状腺组织中SUMO4 mRNA及其蛋白表达情况;采用CCK8和Transwell实验检测SUMO4沉默后对PTC细胞株CGTHW-3增殖和迁移的影响.结果：SUMO4 mRNA及蛋白
目的：探讨miRNA-155对乳腺癌细胞增殖和迁移能力的影响,研究MiRNA-155影响乳腺癌细胞功能改变的作用机制.方法：通过转染技术建立过表达及缺表达miRNA-155的乳腺癌MDA-MMB-231细胞系,并用Real-time PCR验证转染情况;通过MTS法和平板克隆形成实验检测转细胞增殖能力的改变;Transwell迁移试验和细胞划痕试验检测细胞迁移和侵袭能力的改变;在此基础上通过Rea
目的：检测Gankyrin在PTC、桥本氏甲状腺炎(HT)及正常甲状腺组织的表达情况并探讨Gankyrin蛋白表达与PTC临床病理特征的关系;分析Gankyrin在PTC及HT同向改变的意义,为两种疾病的关系提供新的证据;观察Gankyrin沉默后对PTC细胞增殖及迁移的影响并分析其可能的分子机制.方法：采用实时荧光定量PCR(Real-time PCR)、Western blot和免疫组化检测G
本文主要讲述了食管癌和责门癌在无远处转移的情况下，采用以手术为主的综合治疗。进行了术前检查，陈述了手术适应证及禁忌证和手术原则及技术规范，以及对术后病理标本的处理，并进行了术后随访。
1.Experiment Aim Endocrine therapy resistance is a major clinical challenge in the treatment of breast cancer, which develops in two thirds of patients (Jordan & OMalley, 2007).The molecular mechanism
Background/Aims We aimed to evaluate the efficacy and safety of an immunosuppressive regimen without steroids in liver transplantation (LT) for hepatitis B virus (HBV)-related hepatocellular carcinoma
Liver grafts from donation after cardiac death (DCD) are associated with inferior clinical outcome and a high discard rate because of poor graft quality.We investigated the predictive value of DCD liv
Background Platelet to lymphocyte ratio (PLR) is a prognostic factor for various tumors, but the current opinion on the prognostic value of PLR in liver transplantation (LT) for hepatocellular carcino